MARGENZA ratings & reviews

Margetuximab
Company: MacroGenic
Brand: MARGENZA
Drug class: Antineoplastic and Immunomodulating Agents
+4 more
Antineoplastic and Immunomodulating Agents, Antineoplastics, Antineoplastic Monoclonal Antibodies, Antineoplastic Monoclonal Antibodies Targeting Growth Factor Receptors and their Ligands, Antineoplastic Monoclonal Antibodies Targeting HER2/neu
Overall rating
3.5
full star full star full star half star empty star
Ranked #38
Physician ratings
  • Efficacy: effective for its intended use
  • Safety: safe to use in humans
  • Tolerability: low drug side effects
  • Accessibility: insurance/payer coverage, cost, affordability,formulary coverage, availability in your hospital or practice setting
  • Adherence: patient compliance with treatment
Efficacy
3.6/5
Safety
3.6/5
Tolerability
3.6/5
Accessibility
3.5/5
Adherence
3.5/5

Sermo AI Overview

  • MARGENZA's effectiveness in treating breast cancer is viewed with some uncertainty, as reflected by a neutral average rating of 3.5 among specialists, indicating mixed opinions about its performance compared to other treatments.
  • Healthcare professionals generally consider MARGENZA to be safe and tolerable, achieving favorable scores of 4 for these aspects. Nonetheless, there are issues with accessibility and adherence, suggesting potential areas for improvement.
  • Was this summary helpful?
Based on insights from Sermo’s triple verified physicians

Description

Margenza contains the active ingredient margetuximab-cmkb, a HER2/neu receptor antagonist and monoclonal antibody. This drug is available as an injectable solution for intravenous use, with each single-dose vial containing 250 mg of the active ingredient. Key inactive ingredients include L-arginine hydrochloride, polysorbate 80, and sucrose. It is a clear to slightly opalescent solution that requires dilution before use.

Source: This information is sourced from FDA and powered by AI

Dosage & Administration

How should I use this medication?

This medication is infused into a vein. It is given by your care team in a hospital or clinic setting.

Talk to your care team about the use of this medication in children. Special care may be needed.

Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once.

NOTE: This medicine is only for you. Do not share this medicine with others.

What if I miss a dose?

Keep appointments for follow-up doses. It is important not to miss your dose. Call your care team if you are unable to keep an appointment.

Where should I keep my medication?

This medication is given in a hospital or clinic. It will not be stored at home.

NOTE: This sheet is a summary. It may not cover all possible information. If you have questions about this medicine, talk to your doctor, pharmacist, or health care provider.

Side Effects

What side effects may I notice from receiving this medication?

Side effects that you should report to your care team as soon as possible:

  • Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat
  • Heart failure—shortness of breath, swelling of the ankles, feet, or hands, sudden weight gain, unusual weakness or fatigue
  • Infusion reactions—chest pain, shortness of breath or trouble breathing, feeling faint or lightheaded

Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):

  • Bone, joint, or muscle pain
  • Diarrhea
  • Hair loss
  • Headache
  • Nausea
  • Pain, tingling, or numbness in the hands or feet
  • Unusual weakness or fatigue

This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Warnings & Precautions

What should I tell my care team before I take this medication?

They need to know if you have any of these conditions:

  • Heart failure
  • An unusual or allergic reaction to margetuximab, other medications, foods, dyes, or preservatives
  • Pregnant or trying to get pregnant
  • Breast-feeding

What may interact with this medication?

  • Certain types of chemotherapy, such as daunorubicin, doxorubicin, epirubicin, idarubicin

This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.

What should I watch for while using this medication?

Your condition will be monitored carefully while you are receiving this medication.

Talk to your care team if you may be pregnant. Serious birth defects can occur if you take this medication during pregnancy and for 4 months after the last dose. You will need a negative pregnancy test before starting this medication. Contraception is recommended while taking this medication and for 4 months after the last dose. Your care team can help you find the option that works for you.

Do not breastfeed while taking this medication and for 4 months after the last dose.

What are the most serious risks of this medication?

If you can become pregnant, you will need a test to make sure you are not pregnant before starting this medication. You must use contraception while taking this medication. You may need to keep using contraception even after you stop taking the medication. This depends on the medication. It is important to talk to your care team about how long to use contraception. Call your care team right away if you think you may be pregnant, have unprotected sex, or if you think your contraception did not work.

This medicine may cause heart problems, including decreased heart function or heart failure.

Source: This information is sourced from Elsevier Inc.

Disclaimer

The reviews, ratings, comments, and opinions expressed on this platform are solely those of the individual medical professionals who posted them and do not reflect the views or positions of Sermo, Inc. Sermo does not endorse, verify, or validate the content of individual reviews. The information provided is user-generated and reflects personal clinical experiences, which may not be complete, accurate, or applicable to your specific health needs. It is not intended as medical advice.

Prescription medications affect individuals differently, and what works for one person may not work for another. Always consult your doctor, pharmacist, or other qualified healthcare provider to ensure the information displayed applies to your personal circumstances. Only a licensed healthcare provider can advise you on what is safe and effective for you.

Keep all medications out of the reach of children, never share your medicine with others, and use each medication only as prescribed. Your reliance on any information provided on this platform is at your own risk.

Terms of use

  1. Sermo Drug Ratings, and all information provided on this website, may not be used in combination with any artificial intelligence tool (including to train an algorithm, test, process, analyze, generate output and/or develop any form of artificial intelligence tool). 

  2. Visitors to the online patient-facing website at Sermo.com (“Sermo Drug Ratings”) are Authorized Users of the website, which contains data owned by a third-party provider, Elsevier, Inc.  Accordingly, by visiting Sermo Drug Ratings, Authorized User acknowledges that the website includes Elsevier owned data that Sermo licenses pursuant to a separate usage and Data agreement (the “Agreements”).  Authorized User further acknowledges that Sermo is a third-party beneficiary of the Agreements and Authorized User’s use of the website hereby binds them to the terms of the Agreements; provided, however, that Elsevier shall have no obligations or liability to an Authorized User whatsoever pursuant to the terms of the Agreements.

  3. Authorized User acknowledges and agrees that the Elsevier Products are designed for and are intended to be used by those residing in the United States, and that the information contained in the Elsevier Products does not comply with any laws or practices outside of the United States. You assume all responsibilities, duties, and obligations for any treatment, decision, or advice made or given to third parties as a result of the use or application of the Elsevier Products outside of the United States, and Sermo, Elsevier and its affiliates, subsidiaries, agents and suppliers will incur no liability for any use or application of the Products by Authorized Users outside of the United States.

Welcome to Sermo's Drug Ratings

Previously only for members, Sermo Drug Ratings are now openly available to all healthcare providers, patients, and industry professionals to support better healthcare decisions.

Clinical expertise
Insights based on real prescribing experience from triple-verified practicing physicians only
Detailed insights
Ratings on key attributes including efficacy, safety, tolerability, accessibility, and adherence
Unbiased reviews
Independent, physician-only reviews, free from pharmaceutical industry influence